Novel CYP11B-ligand 123/131IIMAZA as promising theranostic tool for adrenocortical tumors: comprehen...
Novel CYP11B-ligand 123/131IIMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
Adrenal tumors represent a diagnostic and therapeutic challenge. Promising results have been obtained through targeting the cytochrome P450 enzymes CYP11B1 and CYP11B2 for molecular imaging, and [123/131I]iodometomidate ([123/131I]IMTO) has even been successfully introduced as a theranostic agent. As this radiopharmaceutical shows rapid metabolic i...
Alternative Titles
Full title
Novel CYP11B-ligand 123/131IIMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2548405321
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2548405321
Other Identifiers
ISSN
1619-7089
E-ISSN
1619-7089
DOI
10.1007/s00259-021-05477-y
